Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467460) titled 'Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease' on March 9.
Study Type: Observational [Patient Registry]
Primary Sponsor: Neuromed IRCCS
Condition:
PARKINSON DISEASE (Disorder)
Alzheimer s Disease
Diabete Type 2
Recruitment Status: Recruiting
Date of First Enrollment: February 17, 2026
Target Sample Size: 500
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07467460
Published by HT Digital Content Services with permission from Health Daily Digest....